QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Pentagon launches $20M brain-injury diagnostic pilot for combat troops

H.R. 6823 — To direct the Secretary of Defense to establish a pilot program to facilitate the development of certain traumatic brain injury diagnostics for members of the Armed Forces. · Filed by Lori Trahan (D-MA) · 5 cosponsors · Introduced Dec 17, 2025 · Referred to committee

85%
Transparency
Typical bill: 82%
5/100
Hidden-provision risk
Typical bill: 15/100
Military Health Research Initiative

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill directs the Department of Defense to establish a four-year pilot program (2026–2029) to develop and test diagnostic tools that can quickly and accurately identify traumatic brain injuries in military personnel, especially in combat zones. The program will award up to $20 million in grants to companies and research institutions to research, develop, and produce these diagnostic technologies, with preference given to firms with proven track records in defense technology or those willing to work with the military for the first time.

Why we flagged it

The bill is a straightforward appropriations and program-establishment measure focused on advancing diagnostic capability for a specific military health challenge. It is not a tax provision, deregulation, or corporate carve-out; it is a targeted research and development pilot with defined scope, timeline, and reporting requirements.

What the text implies

  • The program's emphasis on 'nontraditional defense contractors' may accelerate adoption of commercial medical-tech startups into the defense supply chain, potentially creating long-term procurement relationships beyond the pilot period.
  • Preference criteria favor entities with existing defense-industry relationships, which may concentrate grant awards among established contractors rather than truly novel entrants.

The full analysis lists 4 implications of this text.

Who stands to gain

medical device manufacturers; biotech firms specializing in diagnostic tools; defense contractors with medical-tech divisions

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record